본문으로 바로가기

기술동향

ESF Scientific Forward Look on Nanomedicine

  • 등록일2005-02-27
  • 조회수10053
  • 분류기술동향 > 플랫폼바이오 > 바이오융합기술
  • 자료발간일
    2005-08-18
  • 출처
    European Science Foundation
  • 원문링크
  • 키워드
    #ESF#Nanomedicine
  • 첨부파일

출처: European Science Foundation

 

ESF Scientific Forward Look on Nanomedicine

 
 
[Contents]
Ⅰ. Introduction
Ⅱ. Background
Ⅲ. Statements and Recommendations
  1. Scientific Trends
  2. Research Strategy and Policy
Ⅳ. References
Ⅴ. Steering Committee 
[Foreword]
 
Recent years have witnessed an unprecedented growth in research in the area of nanoscience. There is increasing optimism that nanotechnology applied to medicine will bring significant advances in the diagnosis and treatment of disease. However, many challenges must be overcome if the application of nanomedicine is to realise improved understanding of the pathophysiological basis of disease, bring more sophisticated diagnostic opportunities and yield more effective therapies. Both the optimism and the challenges have prompted governmental science and funding organisations to undertake strategic reviews of the current status of the field (1-4), their primary objectives being to assess potential opportunities for better healthcare as well as the risk-benefit of these new technologies, and to determine priorities for future funding.
 
In 2004, the European Science Foundation ㅡlaunched its Scientific Forward Look on Nanomedicine. I am pleased to see the successful conclusion of this foresight study, which has been the first such exercise focused on medical applications of nanoscience and nanotechnology. The Forward Look involved leading European experts and led to a definition of the current status of the field and debates on strategic policy issues. This Policy Briefing concentrates on the forward-looking recommendations and in doing so provides only a very brief summary of the indepth discussions which will be fully presented in a detailed report. Implementation of these recommendations should ensure continuing European leading-edge research and development in nanomedicine, resulting in reduced healthcare costs and the rapid realisation of medical benefits for all European citizens. ESF will commit itself to taking the initiative and facilitating the relevant bodies, including ESF Member Organisations and the European Commission, for actions based on these recommendations.
 
 
 

...................(계속)

 

☞ 자세한 내용은 내용바로가기 또는 첨부파일을 이용하시기 바랍니다.

 

관련정보

자료 추천하기

받는 사람 이메일
@
메일 내용